Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 9/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | IDO2 | Q6ZQW0 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | PNMT | P11086 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22964351 | 0.76 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL22964356 | 0.76 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL18361379 | 0.76 | LMNA (0.35) | ALDH1A1LMNA | |
| SCHEMBL2951028 | 0.71 | AHR (0.46) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL28125733 | 0.71 | AHR (0.46) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL254524 | 0.71 | AHR (0.50) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL10867874 | 0.69 | AHR (0.48) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL20604406 | 0.68 | SLC6A2 (0.46) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL20604356 | 0.68 | SLC6A2 (0.46) | SLC6A4SLC6A2SLC6A3ALDH1A1LMNA | |
| SCHEMBL18361378 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170000132-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-01-05 | — | — | US | disclosed |
| US-20170000132-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-01-05 | — | — | US | disclosed |
| WO-2015097237-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2015-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000132-A1 | BENZOXABOROLE FUNGICIDES | CYP4X1, BROX, CYP1B1 | SLC6A4 4033/4885SLC6A2 4015/4885SLC6A3 3619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.